These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34104024)

  • 1. Inter-Day Test-Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD.
    Hansen H; Beyer N; Frølich A; Godtfredsen N; Bieler T
    Patient Relat Outcome Meas; 2021; 12():117-128. PubMed ID: 34104024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis.
    Smid DE; Franssen FM; Houben-Wilke S; Vanfleteren LE; Janssen DJ; Wouters EF; Spruit MA
    J Am Med Dir Assoc; 2017 Jan; 18(1):53-58. PubMed ID: 27624705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility, repeatability, validity and responsiveness of the EQ-5D-3L in Krio for patients with stroke in Sierra Leone.
    Youkee D; Pessima S; Sackley C; Soley-Bori M; Deen GF; Marshall IJ
    Health Qual Life Outcomes; 2024 Mar; 22(1):29. PubMed ID: 38549069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the EQ-5D-3L anxiety or depression domain to the Hospital Anxiety and Depression Scale to identify anxiety or depression after stroke.
    Thayabaranathan T; Andrew NE; Stolwyk R; Lannin NA; Cadilhac DA
    Top Stroke Rehabil; 2022 Mar; 29(2):146-155. PubMed ID: 33726636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the COPD Assessment Test onto EQ-5D.
    Hoyle CK; Tabberer M; Brooks J
    Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS).
    Thuppal S; Markwell S; Crabtree T; Hazelrigg S
    Qual Life Res; 2019 Jul; 28(7):1885-1892. PubMed ID: 30707368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meaningful values of the EQ-5D-3L in patients undergoing primary knee arthroplasty.
    Yapp LZ; Scott CEH; Howie CR; MacDonald DJ; Simpson AHRW; Clement ND
    Bone Joint Res; 2022 Sep; 11(9):619-628. PubMed ID: 36047008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by
    Shah A; Ng X; Shah R; Solem C; Wang P; Obradovic M
    Patient Relat Outcome Meas; 2021; 12():45-54. PubMed ID: 33658880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring quality of life in COPD patients: comparing disease-specific supplements to the EQ-5D-5L.
    Szentes BL; Schwarzkopf L; Kirsch F; Schramm A; Leidl R
    Expert Rev Pharmacoecon Outcomes Res; 2020 Oct; 20(5):523-529. PubMed ID: 31512524
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation and reliability of the Chichewa translation of the EQ-5D quality of life questionnaire in adults with orthopaedic injuries in Malawi.
    Chokotho L; Mkandawire N; Conway D; Wu HH; Shearer DD; Hallan G; Gjertsen JE; Young S; Lau BC
    Malawi Med J; 2017 Jun; 29(2):84-88. PubMed ID: 28955412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of patient-reported outcomes by questionnaires in patients with Moderate and severe chronic obstructive pulmonary disease treated with glycopyrroniUm in the reaL lifE setTing in Hungary (AMULET)].
    Tamási L; Speer G;
    Orv Hetil; 2020 Feb; 161(8):295-305. PubMed ID: 32073290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the EQ-5D-3L for Kashin-Beck disease in China.
    Fang H; Farooq U; Wang D; Yu F; Younus MI; Guo X
    Springerplus; 2016; 5(1):1924. PubMed ID: 27917330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
    Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
    Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD.
    Zanini A; Aiello M; Adamo D; Casale S; Cherubino F; Della Patrona S; Raimondi E; Zampogna E; Chetta A; Spanevello A
    Respir Care; 2015 Jan; 60(1):88-95. PubMed ID: 25336531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
    Crick K; Al Sayah F; Ohinmaa A; Johnson JA
    Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ).
    Tsiligianni IG; van der Molen T; Moraitaki D; Lopez I; Kocks JW; Karagiannis K; Siafakas N; Tzanakis N
    BMC Pulm Med; 2012 May; 12():20. PubMed ID: 22607459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.